It has long been assumed that type 2 diabetes is caused by the combined effects of insulin resistance and loss of pancreatic islet beta cells. Much therapeutic effort has been directed towards decreasing insulin resistance even though results have been generally disappointing. Now that type 2 diabetes can be understood as a simple reversible condition, its component parts can be examined during the period of return to normal glucose tolerance.
Get full access to this article
View all access options for this article.
References
1.
DeFronzoRAEJacotJequierEThe effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterisation.Diabetes1981; 30: 1001-7.
2.
PetersenKFSDufourSavageDB The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.Proc Natl Acad Sci U S A2007; 104: 12587-94.
3.
CassidySCThomaHallsworthKHigh intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial.Diabetologia2016; 59: 56-66.
4.
KimHMHaluzikOGavrilovaYakarSThiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.Diabetologia2004; 47: 2215-25.
5.
TaylorRIMagnussonRothmanDLDirect assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects.J Clin Invest1996; 97: 126-32.
6.
SinghalPCaumoACareyPERegulation of endogenous glucose production after a mixed meal in type 2 diabetes.Am J Physiol Endocrinol Metab2002; 283: E275-83.
7.
TaylorR.Pathogenesis of type 2 diabetes: Tracing the reverse route from cure to cause.Diabetologia2008; 51: 1781-9.
8.
LalloyerFBVandewallePercevaultFPeroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets.Diabetes2006; 55: 1605-13.
9.
LeeYHHiroseMOhnedaJohnsonJHBeta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-B-Cell relationships. Proc Natl Acad Sci U S A1994; 91: 10878-82.
10.
LeeYILingvaySzczepaniakLSPancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes2009; 34: 396-400.
11.
LimELKGHollingsworthAribisalaBSReversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.Diabetologia2011; 54: 2506-14.
12.
StevenSKGHollingsworthAl-MrabehAVery low calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care2016; 39: 808-15.
13.
StevenSTaylorR.Restoring normoglycaemia by use of a very low calorie diet in long versus short duration type 2 diabetes.Diabet Med2015; 32: 1149-55.
14.
WhiteMGJAMShawTaylorR. Type 2 diabetes: The pathologic basis of reversible beta-cell dysfunction. Diabetes Care2016; 39: 2080-8.
15.
TaylorR.Insulin resistance and type 2 diabetes. Diabetes2012; 61: 778-9.
16.
StevenSELimTaylorR.Population response to information on reversibility of type 2 diabetes. Diabet Med2013; 30: e135-8.
17.
LeslieWSIFordSattarNThe Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial.BMC Fam Pract2016; 17: 20.
18.
BruningJCMDMichaelWinnayJNA muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell1998; 2: 55969.
19.
SavageDBLZhaiRavikumarBA prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice.PLoS Med2008; 5: e27.
20.
PetersenKFSDufourBefroyDReversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.Diabetes2005; 54: 603-8.
21.
AdielsMMRTaskinenPackardCOverproduction of large VLDL particles is driven by increased liver fat content in man.Diabetologia2006; 49: 755-65.
22.
PinnickKMNevilleClarkAReversibility of metabolic and morphological changes associated with chronic exposure of pancreatic islet beta-cells to fatty acids. J Cell Biochem2010; 109: 683-92.
23.
TalchaiCSXuanLinHVPancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure.Cell2012; 150: 1223-34.
24.
WhiteMGHLMarshallRigbyRExpression of mesenchymal and alpha-cell phenotypic markers in islet beta-cells in recently diagnosed diabetes. Diabetes Care2013; 36: 3818-20.
25.
TabakAGMJokelaAkbaralyTNTrajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet2009; 373: 2215-21.
26.
TaylorR.Type 2 diabetes: etiology and reversibility. Diabetes Care2013; 36: 1047-55.
